Together with our study of TAF1 in AE-driven AML, these findings demonstrate that TAFs not only participate in RNA polymerase II-mediated general transcription but also function as specialized co-regulators in modulating distinct transcription programs critical for leukemogenesis. The gene discussed is TAF1; the disease is acute myeloid leukemia.